Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$13.58 - $17.36 $448,262 - $573,036
33,009 Added 2.7%
1,254,317 $19.7 Million
Q4 2023

Feb 13, 2024

BUY
$10.11 - $16.54 $856,327 - $1.4 Million
84,701 Added 7.45%
1,221,308 $19.7 Million
Q3 2023

Nov 13, 2023

BUY
$12.46 - $15.48 $338,936 - $421,086
27,202 Added 2.45%
1,136,607 $14.5 Million
Q2 2023

Aug 11, 2023

BUY
$13.28 - $15.96 $575,037 - $691,083
43,301 Added 4.06%
1,109,405 $15.6 Million
Q1 2023

May 15, 2023

BUY
$14.26 - $22.1 $2.21 Million - $3.42 Million
154,710 Added 16.98%
1,066,104 $16.5 Million
Q4 2022

Feb 13, 2023

BUY
$14.85 - $19.04 $500,459 - $641,667
33,701 Added 3.84%
911,394 $14.9 Million
Q3 2022

Nov 14, 2022

BUY
$12.38 - $20.23 $644,837 - $1.05 Million
52,087 Added 6.31%
877,693 $16.2 Million
Q2 2022

Aug 12, 2022

BUY
$9.11 - $13.98 $1.68 Million - $2.58 Million
184,342 Added 28.75%
825,606 $10.9 Million
Q1 2022

May 13, 2022

SELL
$6.87 - $11.11 $976,852 - $1.58 Million
-142,191 Reduced 18.15%
641,264 $5.94 Million
Q4 2021

Feb 11, 2022

BUY
$7.7 - $37.13 $344,166 - $1.66 Million
44,697 Added 6.05%
783,455 $7.65 Million
Q3 2021

Nov 12, 2021

SELL
$26.46 - $37.15 $41,595 - $58,399
-1,572 Reduced 0.21%
738,758 $25.1 Million
Q2 2021

Aug 13, 2021

BUY
$32.73 - $47.95 $1.19 Million - $1.74 Million
36,267 Added 5.15%
740,330 $27.1 Million
Q1 2021

May 12, 2021

BUY
$40.39 - $56.73 $2.07 Million - $2.91 Million
51,224 Added 7.85%
704,063 $31.6 Million
Q4 2020

Feb 12, 2021

BUY
$51.77 - $66.18 $1.84 Million - $2.35 Million
35,552 Added 5.76%
652,839 $37.3 Million
Q3 2020

Nov 13, 2020

BUY
$43.8 - $58.16 $7.29 Million - $9.68 Million
166,519 Added 36.94%
617,287 $31.7 Million
Q2 2020

Aug 13, 2020

BUY
$37.05 - $65.03 $4.26 Million - $7.48 Million
114,990 Added 34.25%
450,768 $26.9 Million
Q1 2020

May 14, 2020

BUY
$33.63 - $69.4 $1.31 Million - $2.7 Million
38,958 Added 13.13%
335,778 $13.8 Million
Q4 2019

Feb 13, 2020

BUY
$31.7 - $69.93 $407,598 - $899,159
12,858 Added 4.53%
296,820 $18.5 Million
Q3 2019

Nov 12, 2019

BUY
$19.95 - $38.85 $1.34 Million - $2.61 Million
67,155 Added 30.97%
283,962 $9.64 Million
Q2 2019

Aug 14, 2019

BUY
$21.05 - $26.21 $738,034 - $918,948
35,061 Added 19.29%
216,807 $4.89 Million
Q1 2019

May 14, 2019

BUY
$20.65 - $29.55 $306,487 - $438,581
14,842 Added 8.89%
181,746 $4.22 Million
Q4 2018

Feb 13, 2019

BUY
$19.08 - $36.14 $518,155 - $981,453
27,157 Added 19.43%
166,904 $3.5 Million
Q3 2018

Nov 13, 2018

BUY
$33.57 - $42.1 $266,982 - $334,821
7,953 Added 6.03%
139,747 $5.41 Million
Q2 2018

Aug 14, 2018

BUY
$20.06 - $44.95 $350,287 - $784,916
17,462 Added 15.27%
131,794 $5.19 Million
Q1 2018

May 15, 2018

SELL
$20.04 - $29.71 $126,632 - $187,737
-6,319 Reduced 5.24%
114,332 $2.29 Million
Q4 2017

Feb 13, 2018

BUY
$16.54 - $24.2 $2 Million - $2.92 Million
120,651
120,651 $2.74 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.